Conceptos Categóricos

Crónicas de autores

Augusto José Ferreira de Matos *

Autor invitado por SIIC

Contribui para o estudo do valor prognóstico do índice de marcação com MIB-1 em tumores mamários malignos espontâneos em cadelas

ÍNDICE MIB-1 COMO FACTOR DE PROGNÓSTICO EM TUMORES MAMÁRIOS DE CADELAS

A relação significativa entre o índice de marcação cm MIB-1 e factores clinico-patológicos de mau prognóstico sugere que este índice pode ter um potencial valor prognóstico em tumores mamários de cadelas.

*Augusto José Ferreira de Matos
describe para SIIC los aspectos relevantes de su trabajo
MIB-1 LABELLING INDICES ACCORDING TO CLINICO-PATHOLOGICAL VARIABLES IN CANINE MAMMARY TUMOURS: A MULTIVARIATE STUDY
Anticancer Research,
26(3A):1821-1826 May, 2006

Esta revista, clasificada por SIIC Data Bases, integra el acervo bibliográfico
de la Biblioteca Biomédica (BB) SIIC.

Institución principal de la investigación
*Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Porto, Portugal, Porto, Portugal
Imprimir nota
Referencias bibliográficas
1. Misdorp W, Else RW, Hellmén E, Lipscomb TP. Histological classification of mammary tumors of the dog and the cat. World Health Organization Histological Classification of Tumors of Domestic Animals, second series, vol. 7, nº 2. Armed Forces Institute of Pathology, Washington, DC, 1999.2. Durchow M, Gerdes J, Schluter C. The proliferation-associated Ki-67 protein: definition in molecular terms. Cell Proliferat 1994; 27:235-242.3. Cattoretti G, Becker MHG, Key G, Duchrow M, Schluter C, Galle J, Gerdes J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detects proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992; 168:357-363.4. McCormick D, Chong H, Hobbs C, Datta C, Hall PA. Detection of Ki-67 antigen in fixed and wax embedded sections with the monoclonal antibody MIB1. Histopathology 1993; 22:355-360.5. Benini E, Rao S, Grazia Daidone M, Pilotti S, Silvestrini R. Immunoreactivity to MIB-1 in breast cancer: methodological assessment and comparison with other proliferation indices. Cell Proliferat 1997; 30:107-115.6. Zacchetti A, Van Garderen E, Teske E, Nederbragt H, Dierendonck JH, Rutteman GR. Validation of the use of proliferation markers in canine neoplastic and non-neoplastic tissues: comparison of KI-67 and proliferating cell nuclear antigen (PCNA) expression versus in vivo bromodeoxuridine labelling by immunohistochemistry. APMIS 2003; 111:430-438.7. Nieto A, Peña L, Pérez Alenza MD, Sánchez MA, Flores JM, Castaño M. Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: Clinical and pathologic associations and prognostic significance. Vet Pathol 2000; 37:239-247.8. Peña L, Nieto A, Pérez Alenza MD, Cuesta P, Castaño M. Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables. J Vet Diagn Invest 1998; 10:237-246.9. Sarli G, Preziosi R, Benazzi C, Castellani G, Marcato PS. Prognostic value of histologic stage and proliferative activity in canine malignant mammary tumors. J Vet Diagn Invest 2002; 14:25-34.10. Löhr CV, Teifke JP, Failing K, Weiss E. Characterization of thee proliferation state in canine mammary tumors by the standardized AgNOR method with postfixation and immunohistologic detection of Ki-67 and PCNA. Vet Pathol 1997; 34:212-221.11. Madewell BR. Cellular proliferation in tumors: a review of methods, interpretation, and clinical applications. J Vet Intern Med 2001; 15:334-340.12. Matosa AJF, Faustino AMR, Lopes C, Rutteman GR, Gärtner F. Detection of lymph node micrometastasis in canine malignant mammary tumours with the use of cytokeratin immunostaining. Vet Rec (in press), 2006.13. Rutteman GR, Withrow SJ, MacEwen EG. Tumors of the mammary gland. In Withrow SJ, MacEwen EG (eds): Small Animal Clinical Oncology, 3rd ed. W. B. Saunders Company, pp 455-477, 2001.14. Elston CW & Ellis IO. Assessment of histological grade. In Rosen PP (ed.) Rosen’s Breast Pathology. Lippincott-Raven Publ., Philadelphia, pp 365-382, 1998.15. Hsu SM, Faine L, Fanger H. A comparative study of the peroxidase-antiperoxidase method and the avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 1981; 75:734-738.16. Matosb AJF, Lopes C, Carvalheira J, Santos M, Rutteman GR, Gärtner F. E-cadherin expression in canine malignant mammary tumours: relationship to other clinico-pathological variables. J Comp Pathol (in press), 2006.17. SAS Institute Inc. SAS/STAT® User’s Guide, Version 6, Fourth Edition, Cary, NC: SAS Institute Inc., 943 pp, 1989.18. Connor AJM, Pinder SE, Elston CW, Bell JA, Wencyk P, Robertson JFR, Blamey RW, Nicholson RI, Ellis IO. Intratumoural heterogeneity of proliferation in invasive breast carcinoma evaluated with MIB1 antibody. The Breast 1997; 6:171-176.19. Geraldes M, Gärtner F, Schmitt F. Immunohistochemical study of hormonal receptors and cell proliferation in normal canine mammary glands and spontaneous mammary tumours. Vet Rec 2000; 146:403-406.20. Castagnaro M, DeMaria R, Bozzetta E, Ru G, Casalone C, Caramelli M. Ki-67 index as indicator of the post-surgical prognosis in feline mammary carcinomas. Res Vet Sci 1998; 65:223-226.21. Dias Pereira P, Carvalheira J, Gärtner F. Cell proliferation in feline normal, hyperplastic and neoplastic mammary tissue-an immunohistochemical study. Vet J 2004; 168:180-185.22. Yamagami T, Kobayashi T, Takahashi K, Sugiyama M. Prognosis for canine malignant tumors based on TNM and histologic classification. J Vet Med Sci 1996; 58:1079-1083.23. Pérez Alenza MD, Peña L, Nieto AI, Castaño M: Clinical and pathological prognostic factors in canine mammary tumors. Ann Inst Sup San 1997; 33:581-585.24. Philibert JC, Snyder PW, Glickman N, Glickman LT, Knapp DW, Waters DJ. Influence of host factors on survival in dogs with malignant mammary gland tumors. J Vet Intern Med 2003; 17:102-106.25. Schmitt FC, Ferreira MP. MIB-1 is a suitable marker of proliferative activity in formalin-fixed, paraffin-embedded sections of breast cancer. Int J Surg Pathol 1995; 2:287-294.26. Barnard NJ, Hall PA, Lemoine NR, Kadar N. Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables. J Pathol 1987; 152:287-295.27. Isola JJ, Helin HJ, Helle Mj, Kallioniemi OP. Evaluation of cell proliferation in breast carcinoma. Comparison of Ki-67 immunohistochemical study, DNA flow cytometric analysis, and mitotic count. Cancer 1990; 65:1180-1184.28. Leonardi E, Girlando S, Serio G, Mauri FA, Perone G, Scampini S, Dalla Palma P, Barbareschi M. PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables. J Clin Pathol 1992; 45:416-419.29. Hyder SM, Chiappetta C, Stancel GM. Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells. Int J Cancer 2001; 92:469-473.30. Wu J, Richer J, Horwitz KB, Hyder SM. Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: Preferential regulation by progesterone receptor B. Cancer Res 2004; 64:2238-2244.31. Kurebayashi J, Kunisue H, Yamamoto S, Kurosumi M, Otsuki T, Sonoo H. Paradoxical hormone responses of KPL-1 breast cancer cells in vivo: A significant role of angiogenesis in tumour growth. Oncology 2000; 59:158-165.32. Veronese SM, Gambacorta M. Detection of Ki-67 proliferation rate in breast cancer. Correlation with clinical and pathological features. Am J Clin Pathol 1991; 95:30-34.33. Hellmén E, Bergström R, Holmberg L, Spångberg I-B, Hansson K, Lindgren A. Prognostic factors in canine mammary tumors: A multivariate study of 202 consecutive cases. Vet Pathol 1993; 30:20-27.34. Shofer FS, Sonnenschein EG, Goldschmidt MH, Laster LL, Glickman LT. Histopathologic and dietary prognostic factors for canine mammary carcinoma. Breast Cancer Res Tr 1898; 13:49-60.
Otros artículos de Augusto José Ferreira de Matos

Matos AJF, Faustino AMR, Lopes C, Rutteman GR, Gärtner F. Detection of lymph node micrometastasis in canine malignant mammary tumours with the use of cytokeratin immunostaining. The Veterinary Record 2006; 158:626-629.Matos AJF, Lopes C, Carvalheira J, Santos M, Rutteman GR, Gärtner F. E-cadherin expression in canine malignant mammary tumours: relationship to other clinico-pathological variables. Journal of Comparative Pathology 2006; 134:182-189.Matos AJF, Mascarenhas C, Magalhães P, Pinto JP. Efficient screening of the cystinuria-related C663T Slc3a1 nonsense mutation in Newfoundland dogs by denaturing high-performance liquid chromatography. Journal of Veterinary Diagnostic Investigation 2006; 18:102-105.

Para comunicarse con Augusto José Ferreira de Matos mencionar a SIIC como referencia:


Autor invitado
29 de junio, 2006
Descripción aprobada
12 de julio, 2006
Reedición siicsalud
3 de febrero, 2010

Acerca del trabajo completo
ÍNDICE MIB-1 COMO FACTOR DE PROGNÓSTICO EM TUMORES MAMÁRIOS DE CADELAS

Título original en castellano
INDICE DE MARCAÇÃO COM MIB-1 E SUA CORRELAÇÃO COM VARIAVEIS CLINICO-PATOLOGICAS EM TUMORES MAMARIOS CANINOS: UM ESTUDO DE MULTIVARIÂNCIA

Autor


Acceso a la fuente original
Anticancer Research
http://ar.iiarjournals.org/

El artículo se relaciona estrictamente con las especialidades de siicsalud


ua40317